-
Something wrong with this record ?
Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy
P. Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Adult MeSH
- Echocardiography MeSH
- Genetic Variation MeSH
- Genetic Testing MeSH
- Genotype MeSH
- Heterozygote MeSH
- Cardiomyopathy, Hypertrophic diagnosis genetics MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Mutation MeSH
- Cardiac Myosins genetics MeSH
- Myosin Heavy Chains genetics MeSH
- Carrier Proteins genetics MeSH
- Troponin T genetics MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Hypertrophic cardiomyopathy is the most common genetic cardiac disease with vast genetic heterogeneity. First-degree relatives of patients with HCM are at 50% risk of inheriting the disease-causing mutation. Genetic testing is helpful in identifying the relatives harbouring the mutations. When genetic testing is not available, relatives need to be examined regularly. We tested a cohort of 99 unrelated patients with HCM for mutations in MYH7, MYBPC3, TNNI3 and TNNT2 genes. In families with identified pathogenic mutation, we performed genetic and clinical examination in relatives to study the influence of genetic testing on the management of the relatives and to study the usefulness of echocardiographic criteria for distinguishing relatives with positive and negative genotype. We identified 38 genetic variants in 47 patients (47 %). Fifteen of these variants in 21 patients (21 %) were pathogenic mutations. We performed genetic testing in 52 relatives (18 of them (35 %) yielding positive results). Genetic testing of one HCM patient allowed us to omit 2.45-5.15 future cardiologic examinations of the relatives. None of the studied echocardiographic criteria were significantly different between the relatives with positive and negative genotypes, with the exception of a combined echocardiographic score (genotype positive vs. genotype negative, 3.316 vs. -0.489, P = 0.01). As a conclusion, our study of HCM patients and their relatives confirmed the role of genetic testing in the management of the relatives and found only limited benefit of the proposed echocardiographic parameters in identifying disease-causing mutation carriers.
Department of Cardiology 2nd Faculty of Medicine Charles University Prague and University
Laboratory for Molecular Genetics and Oncology Genomac Research Institute Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14078166
- 003
- CZ-PrNML
- 005
- 20141107080344.0
- 007
- ta
- 008
- 141105s2014 xr f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)24594054
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Tomašov, Pavol, $d 1982- $7 xx0243010 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
- 245 10
- $a Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy / $c P. Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka
- 520 9_
- $a Hypertrophic cardiomyopathy is the most common genetic cardiac disease with vast genetic heterogeneity. First-degree relatives of patients with HCM are at 50% risk of inheriting the disease-causing mutation. Genetic testing is helpful in identifying the relatives harbouring the mutations. When genetic testing is not available, relatives need to be examined regularly. We tested a cohort of 99 unrelated patients with HCM for mutations in MYH7, MYBPC3, TNNI3 and TNNT2 genes. In families with identified pathogenic mutation, we performed genetic and clinical examination in relatives to study the influence of genetic testing on the management of the relatives and to study the usefulness of echocardiographic criteria for distinguishing relatives with positive and negative genotype. We identified 38 genetic variants in 47 patients (47 %). Fifteen of these variants in 21 patients (21 %) were pathogenic mutations. We performed genetic testing in 52 relatives (18 of them (35 %) yielding positive results). Genetic testing of one HCM patient allowed us to omit 2.45-5.15 future cardiologic examinations of the relatives. None of the studied echocardiographic criteria were significantly different between the relatives with positive and negative genotypes, with the exception of a combined echocardiographic score (genotype positive vs. genotype negative, 3.316 vs. -0.489, P = 0.01). As a conclusion, our study of HCM patients and their relatives confirmed the role of genetic testing in the management of the relatives and found only limited benefit of the proposed echocardiographic parameters in identifying disease-causing mutation carriers.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a srdeční myosiny $x genetika $7 D024722
- 650 _2
- $a hypertrofická kardiomyopatie $x diagnóza $x genetika $7 D002312
- 650 _2
- $a transportní proteiny $x genetika $7 D002352
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a echokardiografie $7 D004452
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetické testování $7 D005820
- 650 _2
- $a genetická variace $7 D014644
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a těžké řetězce myosinu $x genetika $7 D018995
- 650 _2
- $a troponin T $x genetika $7 D020107
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Minárik, Marek, $d 1970- $7 xx0071043 $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic
- 700 1_
- $a Zemánek, David, $d 1972- $7 xx0079099 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Čadová, Pavla $7 xx0257532 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Homolová, Stanislava $7 _AN033515 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Čurila, Karol $7 xx0073736 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Pěnička, Martin $7 xx0083039 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Mináriková, Lucie $7 xx0105258 $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic
- 700 1_
- $a Belšánová, Barbora $u Laboratory for Molecular Genetics and Oncology, Genomac Research Institute, Prague, Czech Republic. $7 xx0258802
- 700 1_
- $a Gregor, Pavel, $d 1952- $7 jn20000400806 $u Third Department of Internal Medicine - Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Veselka, Josef, $d 1965- $7 pna2005261820 $u Department of Cardiology, Second Faculty of Medicine, Charles University in Prague and University
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 60, č. 1 (2014), s. 28-34
- 856 41
- $u https://fb.cuni.cz/file/5712/FB%2060%2001%2004-www.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20141105 $b ABA008
- 991 __
- $a 20141105141547 $b ABA008
- 999 __
- $a ok $b bmc $g 1046626 $s 877154
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 60 $c 1 $d 28-34 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20141105